Abeona Therapeutics Inc. (ABEO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 11:19AM EDT. Market open.
| Previous Close | 4.7700 |
| Open | 4.7900 |
| Bid | 4.6500 x 800 |
| Ask | 4.6700 x 2200 |
| Day's Range | 4.5800 - 4.7900 |
| 52 Week Range | 0.2700 - 34.0000 |
| Volume | |
| Avg. Volume | 168,798 |
| Market Cap | 27.669M |
| Beta (5Y Monthly) | 1.05 |
| PE Ratio (TTM) | 0.11 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
F-star (FSTX) Stock Rises on Buyout Offer From Sino Biopharm
Sino Biopharmaceutical, through its wholly-owned subsidiary, is set to acquire F-star (FSTX) for $7.12 per share in cash. The transaction is likely to close by second-half 2022.
- Zacks
bluebird (BLUE) Up as FDA Nod Likely for Thalassemia Therapy
Based on briefing documents issued by the FDA, a positive regulatory approval is expected on bluebird bio's (BLUE) gene-therapy for treating thalassemia.
- Zacks
AstraZeneca (AZN) Breast Cancer Drug Cuts Risk of Death to Half
Data from a late-stage study shows that AstraZeneca's (AZN) Enhertu meets superior and clinically meaningful progression-free survival and overall survival in HER2-low metastatic breast cancer patients.
© 2022 Yahoo. All rights reserved.
